Corporate Results

Net profit of Aragen Life Sciences declined 47.80% to Rs 33.14 crore in the quarter ended March 2024 as against Rs 63.49 crore during the previous quarter ended March 2023. Sales declined 4.86% to Rs 414.26 crore in the quarter ended March 2024 as against Rs 435.40 crore during the previous quarter ended March 2023.

For the full year,net profit declined 27.00% to Rs 158.12 crore in the year ended March 2024 as against Rs 216.60 crore during the previous year ended March 2023. Sales declined 4.55% to Rs 1657.58 crore in the year ended March 2024 as against Rs 1736.60 crore during the previous year ended March 2023.

Particulars	Quarter Ended			Year Ended
?	Mar. 2024	Mar. 2023	% Var.	Mar. 2024	Mar. 2023	% Var.
Sales	414.26	435.40	-5	1657.58	1736.60	-5
OPM %	24.33	30.35	-	26.10	28.64	-
PBDT	97.91	130.66	-25	416.62	473.84	-12
PBT	48.55	87.20	-44	224.83	306.55	-27
NP	33.14	63.49	-48	158.12	216.60	-27

Powered by Capital Market - Live News